THAP10
THAP domain-containing protein 10
Also known as: THA10_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9P2Z0
- Gene
- THAP10
- Ensembl
- ENSG00000129028
- Chromosome
- 15
- Canonical length
- 257 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Golgi apparatus,Cytosol
OverviewNCBI Gene
This gene encodes a member of a family of proteins sharing an N-terminal Thanatos-associated domain. The Thanatos-associated domain contains a zinc finger signature similar to DNA-binding domains. This gene is part of a bidirectional gene pair on the long arm of chromosome 15 that is regulated by estrogen and may play a role in breast cancer. [provided by RefSeq, Nov 2010]
Canonical amino-acid sequenceUniProt
257 residues, UniProt reviewed canonical sequence.
>Q9P2Z0|THAP10
1 MPARCVAAHC GNTTKSGKSL FRFPKDRAVR LLWDRFVRGC RADWYGGNDR SVICSDHFAP
61 ACFDVSSVIQ KNLRFSQRLR LVAGAVPTLH RVPAPAPKRG EEGDQAGRLD TRGELQAARH
121 SEAAPGPVSC TRPRAGKQAA ASQITCENEL VQTQPHADNP SNTVTSVPTH CEEGPVHKST
181 QISLKRPRHR SVGIQAKVKA FGKRLCNATT QTEELWSRTS SLFDIYSSDS ETDTDWDIKS
241 EQSDLSYMAV QVKEETCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against THAP10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 10 nTPM
Expression across tissuesHPA
Tissue
- retina: 10 nTPM
- cerebellum: 7.8 nTPM
- cerebral cortex: 7.2 nTPM
- spinal cord: 7.2 nTPM
- hypothalamus: 6 nTPM
- basal ganglia: 5.8 nTPM
Single-cell type
- parietal cells: 46 nCPM
- oocytes: 32 nCPM
- epicardial cells: 30 nCPM
- late primary spermatocytes: 27 nCPM
- retinal bipolar cells: 15 nCPM
- respiratory ciliated cells: 9.7 nCPM
Immune cell
- non-classical monocyte: 4.2 nTPM
- myeloid DC: 0.6 nTPM
- intermediate monocyte: 0.5 nTPM
- NK-cell: 0.4 nTPM
- classical monocyte: 0.3 nTPM
- memory B-cell: 0.3 nTPM
Brain region
- thalamus: 11 nTPM
- cerebral cortex: 10 nTPM
- cerebellum: 10 nTPM
- white matter: 9.6 nTPM
- midbrain: 8.8 nTPM
- pons: 8.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 0.48
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads THAP10 as an antibody target. Whether an autoantibody or antibody against THAP10 could matter depends on whether native THAP10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
THAP10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label THAP10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...